End-of-year message from EMA’s Executive Director, Emer Cooke
2024 achievements in medicine regulation
A common EU approach to data transparency in medicine regulation
Revised guidance on commercially confidential information and personal data
Electronic product information pilot paves way for implementation in regulatory procedures
New report outlines recommendations and next steps
Human medicines committee meeting: December 2024 highlights
CHMP recommends 17 new medicines for approval in the EU
Management Board: highlights of December 2024 meeting
Work programme and budget for 2025
Find medicine
Find information on centrally authorised medicines
What's new
Find all new and updated information published on our website in one place
FAQs
Find answers to the most frequent asked questions we receive
Latest news
EMA and HMA update principles for identification and disclosure of commercially confidential information and personal data
EMA's Executive Director shares her end-of-year message and takes stock of EMA's work in 2024
The European Medicines Agency's (EMA) office is closed from 18:00 on 19 December 2024 to 08:30 on 6 January 2025
Report outlines recommendations and next steps
Work programme and budget for 2025 among other topics
Emcitate can be used in patients of all ages
Information for you
Patients and carers
Featured news and updates for patients and carers.
Healthcare professionals
Featured news and updates for healthcare professionals, including doctors, nurses and pharmacists.
Animal health professionals
Featured news and updates for animal health professionals and users of veterinary medicines such as pet owners.
Pharmaceutical Industry
Featured news and updated for pharmaceutical industry stakeholders active in the human and veterinary medicines fields.
Media
Featured news and updates for journalists
Academia
Featured news and updated for European Academics and researchers in the field of medicine development.